Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 MV Microvascular Endothelial Cell Growth Medium SingleQuotsTM supplements (CC-4147) required for growth of Microvascular Endothelial Cells
KBMTM Keratinocyte Basal Medium, Calcium Free, 500 mL
Complete cell culture kit containing a cryopreserved ampule of mammary epithelial cells (catalog no. CC-2551) and MEGMTM BulletKitTM Mammary Epithelial Cell Growth Media (catalog no. CC-3150) for culture of Mammary Epithelial Cells.
SingleQuotsTM Kit for adipogenic differentiation of mesenchymal stem cells
Annual WinKQCLTM Software Advanced Support for Cat. No. 25-612
Annual WinKQCLTM Software Advanced Support for Cat. No. 25-611
WinKQCLTM 6 Endotoxin Detection and Analysis Software Package fully-integrated, 21CFR part 11 compliant solution for quantitative endotoxin detection analysis, data management, reporting, and trending. (E-delivery)
-
A 3D Bioprinted Model to Study Osteogenic Differentiation of Primary Mesenchymal Stem CellsLearn from this white paper how a 3D bioprinted model using hMSCs can be used for evaluation of bioink compatibility and bioprinting processes.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
The Cell and Gene Therapies Journey from Translation to CommercializationDownload our comprehensive eBook on how to accelerate cell and gene therapy development, from translation to GMP production and commercialization.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat CellsHigh throughput transfection of siRNA libraries has become a valuable tool in target identifi cation and validation. However, such screenings have so far been constrained to mostly easy-totransfect adherent cell lines. Lonza’s 96-well Shuttle® System, based on the well-established Amaxa® Nucleofector® Technology, extends these approaches to primary and diffi cult-to-transfect cells.
-
Webinar - Hepatocytes in the Drug Development PipelineOverview of how primary hepatocytes are used in drug development
-
Transfection of Primary Human HepatocytesEfficient Transfection and Sustained Long Term Functionality
-
Predicting Antibody Dependent Cell-Mediated Cytotoxicity (ADCC)Genotypic and Phenotypic Screening of Human Peripheral Blood Mononuclear Cells
-
Efficient Transfection of Cancer Cell Lines Using the 4D-Nucleofector™ SystemProduct data sheet showing efficient tranfection of cancer cell lines